188 related articles for article (PubMed ID: 12861345)
1. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.
Cacabelos R; Alvarez A; Lombardi V; Fernández-Novoa L; Corzo L; Pérez P; Laredo M; Pichel V; Hernández A; Varela M; Figueroa J; Prous J; Windisch M; Vigo C
Drugs Today (Barc); 2000 Jul; 36(7):415-99. PubMed ID: 12861345
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics and therapeutic prospects in dementia.
Cacabelos R
Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():28-47. PubMed ID: 18344047
[TBL] [Abstract][Full Text] [Related]
4. Novel Therapeutic Strategies for Dementia.
Cacabelos R; Torrellas C; Carrera I; Cacabelos P; Corzo L; Fernández-Novoa L; Tellado I; Carril JC; Aliev G
CNS Neurol Disord Drug Targets; 2016; 15(2):141-241. PubMed ID: 26831267
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics for the treatment of dementia.
Cacabelos R
Ann Med; 2002; 34(5):357-79. PubMed ID: 12452480
[TBL] [Abstract][Full Text] [Related]
6. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
Lahiri DK; Rogers JT; Greig NH; Sambamurti K
Curr Pharm Des; 2004; 10(25):3111-9. PubMed ID: 15544501
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.
Cacabelos R; Naidoo V; Martínez-Iglesias O; Corzo L; Cacabelos N; Pego R; Carril JC
Methods Mol Biol; 2022; 2547():275-387. PubMed ID: 36068470
[TBL] [Abstract][Full Text] [Related]
8. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
Mazumder MK; Choudhury S
Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development.
Dave BP; Shah YB; Maheshwari KG; Mansuri KA; Prajapati BS; Postwala HI; Chorawala MR
Cell Mol Neurobiol; 2023 Nov; 43(8):3847-3884. PubMed ID: 37725199
[TBL] [Abstract][Full Text] [Related]
10. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
Sahoo AK; Dandapat J; Dash UC; Kanhar S
J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.
Cacabelos R; Cacabelos P; Torrellas C; Tellado I; Carril JC
Methods Mol Biol; 2014; 1175():323-556. PubMed ID: 25150875
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
16. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease pathogenesis and therapeutic interventions.
Parihar MS; Hemnani T
J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
[TBL] [Abstract][Full Text] [Related]
18. Promising Therapies for Alzheimer's Disease.
Confaloni A; Tosto G; Tata AM
Curr Pharm Des; 2016; 22(14):2050-6. PubMed ID: 26876218
[TBL] [Abstract][Full Text] [Related]
19. Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
Nagori K; Pradhan M; Sharma M; Ajazuddin ; Badwaik HR; Nakhate KT
Curr Alzheimer Res; 2024 Mar; ():. PubMed ID: 38529600
[TBL] [Abstract][Full Text] [Related]
20. Update on the pharmacological treatment of Alzheimer's disease.
Massoud F; Gauthier S
Curr Neuropharmacol; 2010 Mar; 8(1):69-80. PubMed ID: 20808547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
